Tyche Wealth Partners LLC Regulus Therapeutics Inc. Transaction History
Tyche Wealth Partners LLC
- $442 Billion
- Q3 2024
A detailed history of Tyche Wealth Partners LLC transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Tyche Wealth Partners LLC holds 106,089 shares of RGLS stock, worth $157,011. This represents 0.04% of its overall portfolio holdings.
Number of Shares
106,089
Previous 10,395
920.58%
Holding current value
$157,011
Previous $18.6 Million
797.66%
% of portfolio
0.04%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RGLS
# of Institutions
69Shares Held
53.1MCall Options Held
155KPut Options Held
34.2K-
Federated Hermes, Inc. Pittsburgh, PA12.9MShares$19 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.25MShares$9.25 Million0.17% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$7.4 Million1.32% of portfolio
-
Octagon Capital Advisors LP New York, NY4.26MShares$6.31 Million1.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.05MShares$6 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $21.7M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...